| Park, Sang-Won; Tasneen, Rokeya; Converse, Paul J et al. (2017) Immunodeficiency and Intermittent Dosing Promote Acquired Rifamycin Monoresistance in Murine Tuberculosis. Antimicrob Agents Chemother 61: |
| Ordonez, Alvaro A; Tasneen, Rokeya; Pokkali, Supriya et al. (2016) Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9. Dis Model Mech 9:779-88 |
| Li, Si-Yang; Irwin, Scott M; Converse, Paul J et al. (2015) Evaluation of moxifloxacin-containing regimens in pathologically distinct murine tuberculosis models. Antimicrob Agents Chemother 59:4026-30 |
| Dutta, Noton K; Alsultan, Abdullah; Gniadek, Thomas J et al. (2013) Potent rifamycin-sparing regimen cures guinea pig tuberculosis as rapidly as the standard regimen. Antimicrob Agents Chemother 57:3910-6 |
| Dutta, Noton K; Alsultan, Abdullah; Peloquin, Charles A et al. (2013) Preliminary pharmacokinetic study of repeated doses of rifampin and rifapentine in guinea pigs. Antimicrob Agents Chemother 57:1535-7 |
| Dutta, Noton K; Illei, Peter B; Peloquin, Charles A et al. (2012) Rifapentine is not more active than rifampin against chronic tuberculosis in guinea pigs. Antimicrob Agents Chemother 56:3726-31 |
| Rosenthal, Ian M; Tasneen, Rokeya; Peloquin, Charles A et al. (2012) Dose-ranging comparison of rifampin and rifapentine in two pathologically distinct murine models of tuberculosis. Antimicrob Agents Chemother 56:4331-40 |
